Vertex Pharmaceuticals is downgraded to Hold ahead of Q4 earnings due to underwhelming growth from key new drugs. Click for ...
The Department of Posts and NSE have signed an MoU to distribute mutual funds through the NSE MF Invest platform, aiming to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results